Clinical Evidence Strategy for EU MDR Compliance
Build a defensible clinical evidence plan for EU MDR with expert support on CER strategy, PMCF adequacy, equivalence assessment, and Notified Body readiness. Elexes helps medical device manufacturers align clinical data, risk management, and technical documentation so submissions are scientifically rigorous, audit-ready, and structured to support CE marking with fewer avoidable delays.
Our Clinical Evidence Strategy Services
Focused EU MDR clinical and regulatory support for evidence planning, documentation strength, and submission readiness.
CER Support
Develop or strengthen Clinical Evaluation Reports with structured literature review, appraisal, analysis, and report writing aligned to EU MDR and MEDDEV expectations.
PMCF Review
Assess whether your PMCF plans and reports are proportionate, adequately justified, and capable of supporting ongoing clinical evaluation under EU MDR.
Equivalence Assessment
Evaluate the viability of equivalence claims under EU MDR, including access requirements, data sufficiency, and the regulatory risks of relying on comparator devices.
Evidence Gap Analysis
Identify weaknesses across literature, post-market data, clinical investigations, and real-world evidence, then prioritize remediation actions for a stronger submission package.
Technical File Alignment
Connect clinical evidence strategy to GSPR mapping, risk management, SSCP inputs, and Annex II and III documentation for a coherent compliance narrative.
Submission Readiness
Review clinical evidence adequacy before Notified Body engagement so your team can address deficiencies early and move forward with greater confidence.
Evidence That Holds
Turn Clinical Data Into Regulatory Confidence
A strong EU MDR clinical evidence strategy does more than collect data. It defines how literature, PMCF, investigations, and real-world evidence work together to support safety, performance, and benefit-risk conclusions. Elexes helps manufacturers build a defensible plan that aligns with CER expectations, technical documentation, and Notified Body scrutiny, reducing rework and strengthening the path to CE marking.
Trusted By Manufacturers
Success Stories
Supporting medical device teams with stronger evidence strategies and more submission-ready documentation.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Kudos to the Elexes team! They’re always proactive and have provided invaluable support to us with import, labels, and registrations.”
Philip McFerran
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Kudos to the Elexes team! They’re always proactive and have provided invaluable support to us with import, labels, and registrations.”
Philip McFerran
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Kudos to the Elexes team! They’re always proactive and have provided invaluable support to us with import, labels, and registrations.”
Philip McFerran
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Highly recommended! They excelled at regulatory projects, and document control, and grasped our product’s nuances quickly.”
Michal Depa
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for rigorous, practical regulatory and clinical support.
Deep Expertise
50+ years of collective experience across EU MDR, FDA, ISO 13485, and clinical evidence strategy.
End-to-End Support
From evidence planning through technical documentation and post-market alignment, teams get continuity across the compliance lifecycle.
Proven Delivery
250+ successful projects across 200+ product types with structured, measurable regulatory execution.
Flexible Engagement
Project-based, part-time, or embedded support helps manufacturers access senior expertise without adding headcount.
Meet The Elexes Team
Experienced regulatory and clinical specialists for medical devices.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with regulatory, quality, and clinical consulting across global markets. The company has become a trusted partner for organizations seeking practical guidance on approvals, due diligence, technical documentation, and post-market obligations. With 50+ years of collective experience, the Elexes team brings cross-functional expertise spanning EU MDR, FDA, ISO-based quality systems, and clinical evidence development. Their approach is built around structured execution, transparent communication, and documentation that stands up to regulatory scrutiny. Having supported over 200 clients globally across 200+ product types, Elexes focuses on helping manufacturers move from uncertainty to a clear, defensible compliance pathway.
250+ ProjectsSuccessful regulatory and compliance engagements delivered200+ Product TypesExperience across diverse medical device categories90% Audit ClearanceStrong track record in inspection and audit readiness
Frequently Asked Questions
What is clinical evaluation under EU MDR?
Clinical evaluation under EU MDR is the systematic and ongoing process of assessing clinical data to verify a device’s safety, performance, and clinical benefits for its intended purpose. It typically includes literature review, appraisal of relevant data, analysis of post-market information, and documented conclusions in a Clinical Evaluation Report. The process must be methodologically sound, current, and aligned with the device’s risk profile.
How to perform a clinical evaluation?
A clinical evaluation starts with defining the device scope, intended purpose, and applicable claims. From there, manufacturers identify relevant clinical data sources, appraise the quality and relevance of evidence, analyze safety and performance outcomes, and document conclusions in the CER. Under EU MDR, the evaluation must also connect with risk management, PMS, PMCF, and technical documentation to form a coherent regulatory justification.
When do manufacturers need a clinical evidence strategy for EU MDR?
Manufacturers should define a clinical evidence strategy as early as possible, ideally before major testing plans, CER drafting, or Notified Body engagement. It is especially important for higher-risk devices, implantables, novel technologies, and products relying on equivalence. Early strategy work helps determine whether existing literature is sufficient, whether PMCF can close gaps, or whether a clinical investigation may be needed.
What does a strong EU MDR clinical evidence strategy include?
A strong strategy defines the right mix of evidence sources for the device, such as published literature, PMCF outputs, complaint and PMS data, clinical investigations, and real-world evidence. It also addresses equivalence viability, residual risk justification, benefit-risk conclusions, and how evidence will support the CER, SSCP where applicable, and GSPR conformity. The goal is a traceable, defensible evidence framework rather than disconnected documents.
Can literature alone support EU MDR compliance?
Sometimes, but not always. Literature may be sufficient for lower-risk, well-established devices with strong published evidence and limited novelty. However, EU MDR often requires broader support, especially where equivalence is weak, claims are ambitious, or post-market data is limited. Manufacturers frequently need a combination of literature, PMCF, and device-specific data to satisfy Notified Body expectations and justify safety and performance conclusions.
How does PMCF fit into clinical evidence strategy?
PMCF is a core part of the ongoing clinical evaluation lifecycle under EU MDR. It helps confirm continued safety and performance in real-world use, identify emerging risks, and address residual uncertainties that premarket evidence alone may not resolve. A sound clinical evidence strategy defines whether PMCF is required, what methods are proportionate, and how PMCF outputs will feed back into the CER, PMS reports, and risk management updates.
What are common gaps that delay EU MDR clinical submissions?
Common issues include weak literature search methodology, unsupported equivalence claims, outdated CERs, poor linkage between clinical conclusions and risk management, inadequate PMCF rationale, and inconsistent technical documentation. Notified Bodies also scrutinize whether evidence actually supports the intended purpose and claims. Addressing these gaps early through a structured review can prevent deficiency cycles, rework, and avoidable delays in CE marking timelines.
How long does it take to assess clinical evidence readiness?
The timeline depends on device complexity, evidence maturity, and document quality, but a focused readiness assessment can often begin quickly once core files are available. Reviews typically examine CER content, literature methods, PMCF adequacy, risk management linkage, and technical file consistency. The output should be a prioritized action plan so teams know which evidence gaps are critical before engaging a Notified Body.
Still Need EU MDR Guidance?
Talk with our experts about your clinical evidence strategy.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance knowledge
